Drug Pricing Reform and Cost Containment

With the cost of medications in hospitals, outpatient areas, physician offices and at home surging at an unprecedented rate, emphasis is on drug pricing reform and cost management.
340B Drug Discount Program in 2017

The 340B program is under close scrutiny, with stakeholders reviewing its policies, procedures and discounts, among other issues.
Quality Improvement Programs: Hurdles to Optimizing Care
Many QI programs are subject to missteps, but approaches that implement QI essentials can bring healthcare closer to realizing its potential.
Bundled Payments

The philosophical shift in healthcare payment reform is moving away from fee-for-service to a variety of models, including bundled payments that pay for value.
Going Up: What’s Behind the Growth in IVIG Demand

The U.S. market for IVIG continues to grow well over 5 percent annually. What is driving the market demand?
Healthcare Crisis 2030

Meeting the future healthcare needs of aging baby boomers will require tackling the rise of chronic illness, addressing the impact of Alzheimer’s disease and reinventing care models to address the needs of a graying America.
The Growing Profession of Medical Scribes

Medical scribes can help improve patient/physician satisfaction by shifting focus from electronic health records back to the patient.
OPPS 2017 Changes and Opportunities

Recently published proposed changes to the outpatient prospective payment system affect drugs and biologicals. Here are suggestions for how to implement
best practices.
New Part B Drug Payment Models

New proposals, models and rules from the Centers for Medicare and Medicaid Services, the U.S. Food and Drug Administration and the Department of Health and Human Services will affect payments this spring.
Narrative Medicine: How Stories of Illness Affect Caregiving

A physician diagnoses the condition and either treats it or refers the patient to someone else for treatment. End of story. Or is that just the beginning of the story? Narrative medicine challenges the medical model by bringing a new tool to the table: the story of the patient.